arsenic trioxide has been researched along with dithiothreitol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bau, DT; Gurr, JR; Jan, KY; Liu, F; Lynn, S | 1 |
| Cai, X; Huang, X; Zhou, Y | 1 |
| Cai, X; Chen, GQ; Chen, Z; Dai, W; Huang, Y; Jia, PM; Tong, JH; Yu, Y; Zhang, L; Zhao, Q | 1 |
| Kumar, R; Mukhopadhyay, AK; Paul, MK | 1 |
| Altman, JK; Dolniak, B; Glaser, H; Goussetis, DJ; Kroczynska, B; McNeer, JL; Platanias, LC; Sassano, A | 1 |
| Bau, DT; Chang, NW; Hsu, CM; Lin, SS; Sun, SS; Tsai, CW; Tsai, MH; Tsai, RY; Wang, RF; Wu, CN | 1 |
| Bau, DT; Chang, WS; Chung, JG; Hsia, TC; Hsieh, YH; Hsu, CM; Tsai, CW; Yang, MD | 1 |
7 other study(ies) available for arsenic trioxide and dithiothreitol
| Article | Year |
|---|---|
Dithiothreitol enhances arsenic trioxide-induced apoptosis in NB4 cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Caspases; Cells, Cultured; Dithiothreitol; DNA Fragmentation; Drug Synergism; Growth Inhibitors; Humans; Oxides; Reactive Oxygen Species | 1999 |
[Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells].
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Buthionine Sulfoximine; Cell Division; Dithiothreitol; Drug Interactions; Humans; Interferon-alpha; Multiple Myeloma; Oxides; Tretinoin; Tumor Cells, Cultured | 2001 |
Arsenic trioxide-induced mitotic arrest and apoptosis in acute promyelocytic leukemia cells.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Caffeine; Dithiothreitol; Drug Interactions; Humans; Leukemia, Promyelocytic, Acute; Membrane Potentials; Mitochondria; Mitosis; Oxides; Tumor Cells, Cultured | 2003 |
Dithiothreitol abrogates the effect of arsenic trioxide on normal rat liver mitochondria and human hepatocellular carcinoma cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dithiothreitol; Dose-Response Relationship, Drug; Electron Transport Chain Complex Proteins; Environmental Pollutants; Humans; Liver Neoplasms; Male; Membrane Potential, Mitochondrial; Mitochondria, Liver; Oxides; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2008 |
Arsenic trioxide-dependent activation of thousand-and-one amino acid kinase 2 and transforming growth factor-beta-activated kinase 1.
Topics: Acetylcysteine; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Dithiothreitol; Enzyme Activation; Genetic Variation; Hematopoietic Stem Cells; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; MAP Kinase Kinase Kinases; Oxides; Phosphorylation; Protein Kinases; Reactive Oxygen Species; RNA, Small Interfering; Tretinoin; U937 Cells | 2010 |
Synergistic cytotoxic effects of arsenic trioxide plus dithiothreitol on mice oral cancer cells.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Dithiothreitol; Drug Synergism; Male; Mice; Mice, Inbred C57BL; Mouth Neoplasms; Oxides | 2010 |
Dithiothreitol enhanced arsenic-trioxide-induced cell apoptosis in cultured oral cancer cells via mitochondrial dysfunction and endoplasmic reticulum stress.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Comet Assay; Dithiothreitol; DNA Damage; Drug Synergism; Endoplasmic Reticulum Stress; Humans; Membrane Potential, Mitochondrial; Mitochondrial Diseases; Mouth Neoplasms; Oxides; Sulfhydryl Reagents | 2017 |